---
title: "Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295341079.md"
description: "Macquarie maintained a Buy rating on Resmed Inc CHESS Depositary Interests (RMD) and set a price target of A$46.80. This follows a similar Buy recommendation from UBS analyst David Low on August 7. In contrast, Citi maintained a Hold rating on the same securities yesterday."
datetime: "2026-08-10T00:35:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295341079.md)
  - [en](https://longbridge.com/en/news/295341079.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295341079.md)
generator: "portal-rs"
---

# Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)

Macquarie analyst maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh today and set a price target of A$46.80.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In addition to Macquarie, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Buy from UBS’s David Low in a report issued on August 7. However, yesterday, Citi maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [MQG.AU](https://longbridge.com/en/quote/MQG.AU.md)
- [MQBKY.US](https://longbridge.com/en/quote/MQBKY.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?](https://longbridge.com/en/news/297754564.md)
- [ResMed director Peter C. Farrell disposes of 970 common shares worth $227,688.10](https://longbridge.com/en/news/298025395.md)
- [Morgan Stanley Remains a Buy on Integral Diagnostics Ltd. (IDX)](https://longbridge.com/en/news/297468614.md)
- [J.P. Morgan Keeps Their Buy Rating on Qantas Airways Limited (QUBSF)](https://longbridge.com/en/news/297868094.md)
- [Empowered Funds LLC Buys New Shares in ResMed Inc. $RMD](https://longbridge.com/en/news/297397397.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**